4Front Holdings, LLC announced the appointment of David Nathan as Chief Medical Advisor. In addition, Dr. Nathan will serve as a liaison to the Advisory Board for MissionTM, 4Front's branded network of medical marijuana dispensaries, to ensure professional medical expertise remains central to 4Front's overall operations. Dr. Nathan brings to 4Front a wealth of experience not only as a medical advocate for evidence-based cannabis policy, but also as a psychiatrist, writer, speaker, and educator. He is a Distinguished Fellow of the American Psychiatric Association, an honor awarded to psychiatrists who have made significant contributions to the psychiatric profession, and a Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. He is also the founder and board president of Doctors for Cannabis Regulation (DFCR) and was one of the founding steering committee members of New Jersey United for Marijuana Reform. Dr. Nathan was the first physician in New Jersey history to testify in favor of marijuana legalization before the state legislature, and has offered testimony in several other states. He has traveled around the country speaking to physicians, patient groups, industry leaders, government officials and the general public about cannabis as medicine and cannabis policy reform. As Chief Medical Advisor, Dr. Nathan will keep 4Front abreast of new scientific research related to medical cannabis, and offer strategic guidance as it relates to all aspects of patient care, cannabis research, medical safety, medical compliance and administration of cannabis as a medicine. Additionally, Dr. Nathan will provide leadership and oversight for training for Mission's staff as it relates to patient care and medical safety, and for the development and dissemination of educational materials for patients and caregivers. Dr. Nathan will also engage medical professionals through outreach and educational offerings regarding the use of cannabis as a medicine.